RAFAEL HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
RAFAEL HOLDINGS, INC. (RFL) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$92.00 thousand for the 12-month period ending 2022-07-31, per its 10-K filed 2022-10-31.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2022-10-31
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was -$92.00K.
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was -$184.00K, a 2144.44% decline from fiscal 2020.
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2020 was $9.00K.
- RAFAEL HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2019 was -$102.00K, a 170.83% decline from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month as first filed |
|---|---|---|
| 2022-07-31 | -$92.00K 10-K · filed 2022-10-31 | |
| 2021-07-31 | -$184.00K 10-K · filed 2022-10-31 | |
| 2020-07-31 | $9.00K 10-K · filed 2021-10-18 | -$2.00K 10-K · filed 2020-10-29 |
| 2019-07-31 | -$102.00K 10-K · filed 2020-10-29 | $102.00K 10-K · filed 2019-10-04 |
| 2018-07-31 | $144.00K 10-K · filed 2019-10-04 | |
| 2017-07-31 | $1.00K 10-K · filed 2018-10-15 | |
| 2016-07-31 | $6.00K 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |